Robert Buckheit

Role: President and Chief Executive Officer at Imquest Biosciences
Location: Frederick, MD, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Robert Buckheit

Dr. Robert (Bob) Buckheit is President and Chief Scientific Officer of ImQuest…

Experience

President and Chief Executive Officer
Imquest Biosciences
Jan 2004 — Present
ImQuest BioSciences provides broad based, expert and consultative preclinical therapeutic and prevention agent discovery and development services with expertise in infectious diseases (HIV, HCV, HBV, influenza, herpes, microbiology) and cancer.

Skills

Cancer
Cell Biology
Life Sciences
Monoclonal Antibodies
Assay Development
Pharmaceutical Industry
In Vivo
Elisa
Biotechnology
In Vitro
Glp
Biochemistry
Genomics
Infectious Diseases
Protein Chemistry
Drug Discovery
Preclinical Drug Development
Vaccines
Lifesciences
Drug Development
Ind
Biopharmaceuticals
Topical Microbicides
Virology
Topical Medication
Antiviral
Oncology
Clinical Development
Antibodies
Cell
Immunology
Pcr
Cell Culture
Hcv
Molecular Biology
Clinical Trials
Microbiology
High Throughput Screening

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@imquestbio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Imquest Biosciences

Biotechnology Research · 13 employees · Founded 2004 · Frederick, Maryland, United States

ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. As part of our ImQuest SUCCESS platform, we provide expert preclinical research services, including compound screening to define compound efficacy and drug target validation analysis to define the mechanism of action and toxicity of pharmaceutical products. We specialize in the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines for infectious disease and cancer drug development programs. Our preclinical contract research services are comprised of interrelated efficacy-defining components for infectious disease (including microbiology and virology), cancer and women\'s health with parallel evaluations of in vitro and ex vivo toxicity and the pharmaceutical properties and chemical structure of preclinical candidates to efficiently validate you drug target. We are committed to earning our client\'s trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions.

imquestbio.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Robert Buckheit

Experience

President and Chief Executive Officer

Skills

Find verified contacts for anyone on LinkedIn